INTERNATIONAL PATENT: 89BIO, INC. FILES APPLICATION FOR "THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES"

GENEVA, March 4 -- 89BIO, INC. (655 Montgomery Street, Suite 1500San Francisco, California 94111) filed a patent application (PCT/US2024/043581) for "THERAPEUTIC REGIMENS AND METHODS OF TREATMENT OF NASH USING MUTANT FGF-21 PEPTIDE CONJUGATES" on Aug 23, 2024. With publication no. WO/2025/043155, the details related to the patent application was published on Feb 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MANSBACH, Harry H. (c/o 89Bio, Inc.655 Montgomery Street, Suite 1500San Francisco, CA 94111), JOSEPH, Shaji (c/o 89Bio, Inc.655 Montgomery Street, Suite 1500San Francisco, CA 94111)...